Forecasting/Opportunity Assessment

  • BD&L opportunity
  • Target patient identification
  • Market forecast
  • Pipeline/in-line product forecast
  • Bottom–up, top–down forecast
  • User-friendly dynamic forecasting model to facilitate scenario planning
  • Choosing short-range and long-range forecast options
  • Analog analysis and benchmarking

Competitive Intelligence

  • Pipeline insights
  • Clinical and commercial strategy
  • Trial intelligence
  • Disease landscaping
  • Competitive landscape assessment
  • Asset prioritization
  • Indication prioritization

Conference coverage

  • Supporting clients on a specific target or indication coverage
  • Providing timely intelligence
  • Extensive pre-and post-conference support by screening, analyzing, and identifying key abstracts
  • Providing high-value clinical and commercial analytical insight around data presented

Market Intelligence

  • Monitoring performance reports
  • Key performance indicators (KPI) dashboard
  • Value/Volume analysis
  • Data to insight
  • Sales/Spending analysis
  • Prescription pattern analysis
  • Promotional data analysis

Real-world evidence

  • Claim and prescription data analysis
  • Patient switch analysis
  • Gauging source of business
  • Analyzing treatment patterns and sequencing
  • Measuring safety and efficacy outcomes
  • Prescription pattern analysis
  • Tracking the burden of illness

Pricing Analytics

  • Providing country-specific pricing scenario
  • Analyzing duration of treatment and per-unit cost from real-world studies and trial enrollment
  • Analyzing peer-reviewed articles to identify pricing benchmarks, payers and reimbursement scenario

Portfolio Optimization

  • Strategizing for product portfolio
  • Providing continuous support in terms of clinical and commercial rationale about molecules, companies, technology, generic/biosimilar opportunities

KOL Engagement

  • Answering key intelligence questions based on interviews with physicians, stakeholders, company sources, analysts, payers, academic professionals, and patient advocacy groups

Case Studies

Explore our success stories to gain rich insights into the ever-evolving oncology domain and discover the best-in-class solutions to accelerate business growth

Market Assessment

A global pharmaceutical company wished to evaluate the market value of an asset obtained by acquiring a mid-cap company. The new drug class showed the potential to target multiple tumors in combination with their in-house immune checkpoint inhibitor (CPI).

  • Extensive Secondary Research
  • Extensive Primary Research

Epidemiology Assessment

A client based in the US wanted the epidemiology assessment to understand the percentage of solid organ transplant recipients who develop Cutaneous Squamous Cell Carcinoma (cSCC) in 15 countries, including the US, European countries, and countries from APAC.

  • Secondary Assessment
  • Primary Assessment

Competitive Intelligence

A global pharmaceutical company desired a web-based, robust, simplified, and user-friendly interactive dashboard to help their top executive track the evolving CI landscape in HR+/HER2-ve Breast Cancer.

  • Integrative approach
  • CI and Business analytics tools to include multiple types of interactive charts

Interested in our services? Get in touch with our team

Newsletter / Whitepaper

Unlock the significant assessment challenges that oncology researchers should be aware of to understand the specifics of the oncology market landscape and improve market research and growth.

Unlock the Future of Oncology With ASCO Coverage

The American Society of Clinical Oncology ASCO is among the largest and most prestigious oncology conferences. This conference, held yearly, brings together researchers, physicians, and other healthcare professionals worldwide to discuss the most recent breakthroughs in cancer research, diagnosis, and therapy. Connect with DelveInsights experts and discover the best possible solution to proceed further in the oncological market.

asco coverage

Latest news from the Blog

The pharmaceutical and healthcare market is continuously changing and evolving owing to several facets, including new launches, unexpected failures, and unprecedented situations. Do not lose yourself in the ocean of information, and keep track of essential happenings through DelveInsight’s blogs. Subscribe to us for more information.

Relevant Healthcare Expertise

Relevant Healthcare Expertise

  • Experience in working on 20 tumor types
  • In-house epidemiology and competitive intelligence database of oncology indications
Differentiators

Differentiators

DelveInsight Strategic Support

DelveInsight Strategic Support

Proven Record

Proven Record

Get Expert Consultation Now!

We specialize in oncology market solutions for both large and small companies needing an expert perspective to resolve current challenges and to get estimates to maximize outcomes. Our entire team has extensive oncology experience and knowledge.

  • We have more than 600 oncology reports derived through patient-based market models in our repository to provide a better understanding of the oncology market landscape.
  • Our syndicated reports and customized consulting solutions assist oncology companies in making informed decisions.
  • Our extensive oncology domain KOL associated with us, bringing different perspectives and providing innovative thinking to our client strategy solutions.
  • We attend key oncology conferences regularly to monitor changing market dynamics, understand emerging therapies, and take note of evolving treatment paradigms.